ReviewFoods (Basel, Switzerland)2026
Goji Leaves and Buds as Food Resources: Composition, Processing, Safety, and Links to Side-Stream Valorization.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Goji leaves and buds are used as vegetables and teas, but their composition and behavior in formulated foods differ from those of the berries. This critical narrative review examines their phytochemistry, processing, food applications, digestion, and safety, with selected comparisons to berry-processing residues and orchard biomass. The literature includes leaf-tea processing, polysaccharide-modified dough, emulsion delivery systems, and bud-tea or leaf-extract additions to savory foods. Genotype, harvest stage, and extraction account for substantial compositional variation. In food matrices, improvements in rheology, oxidative stability, or flavor depend on formulation and dose-higher inclusion does not consistently improve sensory quality. Simulated digestion and biological models provide preparation-specific findings but do not establish clinical efficacy. Safety evidence includes a short-term toxicology study of one roasted
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.